BSE Live
Jan 02, 16:01Prev. Close
179.75
Open Price
179.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 02, 15:55Prev. Close
179.87
Open Price
179.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
182.19 (205)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 157.17 | 104.31 | 49.80 | 14.90 | 106.85 | |
| Net CashFlow From Operating Activities | 209.94 | 27.40 | 50.09 | 14.06 | 30.80 | |
| Net Cash Used In Investing Activities | -59.53 | -13.48 | -38.81 | -20.73 | -123.01 | |
| Net Cash Used From Financing Activities | -90.15 | -20.78 | 3.38 | -3.47 | -57.75 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 60.27 | -6.86 | 14.67 | -10.14 | -149.96 | |
| Cash And Cash Equivalents Begin of Year | 32.85 | 39.72 | 25.05 | 35.30 | 185.27 | |
| Cash And Cash Equivalents End Of Year | 93.12 | 32.85 | 39.72 | 25.16 | 35.30 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y